Protonitazene, three times more potent than fentanyl, poses a significant public health risk, evidenced by its first associated death case in Los Angeles.
Developed as a substitute for morphine, protonitazene's potency led to it being illegal, showcasing how synthetic opioids can infiltrate the drug market.
The case is unprecedented as it focuses on a death directly tied to protonitazene distribution, underlining the escalating dangers of these designer drugs.
Despite being described as uncommon, drug enforcement agents recognize protonitazene's potential for harm, particularly as a cutting agent in counterfeit pills.
Collection
[
|
...
]